High-throughput drug screening of fine-needle aspiration-derived cancer organoids is a research paper published in STAR Protocols (2020). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA224188
National Institutes of Health
Grant: CA211206-05
National Institutes of Health
Grant: 1K08 CA240901-01A1
The role of Wnt signaling in aggressive thyroid carcinoma
National Institutes of Health
Grant: R37 CA233770-01
National Institutes of Health
Grant: R35GM122516
National Institutes of Health
Grant: 2T32GM007628-42
American Telemedicine Association
Grant: 2019-0000000090
National Center for Research Resources
Grant: UL1 RR024975-01
American Cancer Society
Grant: 133934-CSDG-19-216-01 -TBG
National Center for Advancing Translational Sciences
Grant: 2 UL1 TR000445-06
Vanderbilt-Ingram Cancer Center
Grant: P30 CA68485
National Cancer Institute
Grant: K12CA090625
NCI NIH HHS
Grant: R50 CA211206
NCI NIH HHS
Grant: R37 CA233770
NIGMS NIH HHS
Grant: T32 GM007628
NCATS NIH HHS
Grant: UL1 TR000445
NCI NIH HHS
Grant: R01 CA244188
NCI NIH HHS
Grant: K08 CA240901
NCI NIH HHS
Grant: P30 CA068485
NCRR NIH HHS
Grant: UL1 RR024975
National Institutes of Health
Grant: 3P30CA068485-23S2
Cancer Center Support Grant
National Institutes of Health
Grant: 3R35GM122516-07S1
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
National Institutes of Health
Grant: 3UL1RR024975-03S4
The Vanderbilt Institute for Clinical and Translational Research (VICTR) UL1
National Institutes of Health
Grant: 5R37CA233770-04
Combining senescence-inducing and senolytic agents to improve melanoma therapy
National Institutes of Health
Grant: 2K12CA090625-06
Vanderbilt Clinical Oncology Research Career Development Program
National Institutes of Health
Grant: 5T32GM007628-43
Training in Pharmacological Sciences
National Institutes of Health
Grant: 6UL1TR000445-11
The Vanderbilt Institute for Clinical and Translational Research (VICTR)
National Institutes of Health
Grant: 5R50CA211206-08
Cancer Pharmacologist and HTS Scientist
Cincinnati Children’s Research Foundation
V Foundation for Cancer Research
FWCI
0.53
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals